Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering P53 to the Cytoplasm

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 May 3

PMID 23638118

Citations 23

Authors

Cintia Bittar

Shubham Shrivastava

Joydip Bhanja Chowdhury

Paula Rahal

Ratna B Ray

Affiliations

Soon will be listed here.

Abstract

Chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality globally, and often leads to end-stage liver disease. The DNA damage checkpoint pathway induces cell cycle arrest for repairing DNA in response to DNA damage. HCV infection has been involved in this pathway. In this study, we assess the effects of HCV NS2 on DNA damage checkpoint pathway. We have observed that HCV NS2 induces ataxia-telangiectasia mutated checkpoint pathway by inducing Chk2, however, fails to activate the subsequent downstream pathway. Further study suggested that p53 is retained in the cytoplasm of HCV NS2 expressing cells, and p21 expression is not enhanced. We further observed that HCV NS2 expressing cells induce cyclin E expression and promote cell growth. Together these results suggested that HCV NS2 inhibits DNA damage response by altering the localization of p53, and may play a role in the pathogenesis of HCV infection.

Citing Articles

SARS-CoV-2 and the DNA damage response.

Grand R J Gen Virol. 2023; 104(11).

PMID: 37948194 PMC: 10768691. DOI: 10.1099/jgv.0.001918.

P63 and P73 Activation in Cancers with p53 Mutation.

Cai B, Hsu Y, Yeh F, Lin Y, Lu R, Yu S Biomedicines. 2022; 10(7).

PMID: 35884795 PMC: 9313412. DOI: 10.3390/biomedicines10071490.

[Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].

Glitscher M, Hildt E, Bender D Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022; 65(2):228-237.

PMID: 35015106 PMC: 8813796. DOI: 10.1007/s00103-021-03482-y.

Adaptive homeostasis and the p53 isoform network.

Mehta S, Campbell H, Drummond C, Li K, Murray K, Slatter T EMBO Rep. 2021; 22(12):e53085.

PMID: 34779563 PMC: 8647153. DOI: 10.15252/embr.202153085.

Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.

Khatun M, Zhang J, Ray R, Ray R J Virol. 2021; 95(17):e0095221.

PMID: 34160260 PMC: 8354323. DOI: 10.1128/JVI.00952-21.

References

Schregel V, Jacobi S, Penin F, Tautz N . Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3. Proc Natl Acad Sci U S A. 2009; 106(13):5342-7. PMC: 2663979. DOI: 10.1073/pnas.0810950106. View

Tort F, Bartkova J, Sehested M, Orntoft T, Lukas J, Bartek J . Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis. Cancer Res. 2006; 66(21):10258-63. DOI: 10.1158/0008-5472.CAN-06-2178. View

Kuiken C, Simmonds P . Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol. 2008; 510:33-53. DOI: 10.1007/978-1-59745-394-3_4. View

Grakoui A, Wychowski C, Lin C, Feinstone S, Rice C . Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993; 67(3):1385-95. PMC: 237508. DOI: 10.1128/JVI.67.3.1385-1395.1993. View

Sheaff R, Groudine M, Gordon M, Roberts J, Clurman B . Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 1997; 11(11):1464-78. DOI: 10.1101/gad.11.11.1464. View

Lan K, Sheu M, Hwang S, Yen S, Chen S, Wu J . HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene. 2002; 21(31):4801-11. DOI: 10.1038/sj.onc.1205589. View

Weitzman M, Carson C, Schwartz R, Lilley C . Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst). 2004; 3(8-9):1165-73. DOI: 10.1016/j.dnarep.2004.03.018. View

Machida K, Cheng K, Lai C, Jeng K, Sung V, Lai M . Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol. 2006; 80(14):7199-207. PMC: 1489016. DOI: 10.1128/JVI.00321-06. View

Pabla N, Huang S, Mi Q, Daniel R, Dong Z . ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem. 2007; 283(10):6572-83. DOI: 10.1074/jbc.M707568200. View

10.

Tsai W, Chung R . Viral hepatocarcinogenesis. Oncogene. 2010; 29(16):2309-24. PMC: 3148694. DOI: 10.1038/onc.2010.36. View

11.

Yamaga A, Ou J . Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem. 2002; 277(36):33228-34. DOI: 10.1074/jbc.M202304200. View

12.

Zannini L, Lecis D, Lisanti S, Benetti R, Buscemi G, Schneider C . Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import. J Biol Chem. 2003; 278(43):42346-51. DOI: 10.1074/jbc.M303304200. View

13.

Hsu I, Tokiwa T, Bennett W, Metcalf R, Welsh J, Sun T . p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis. 1993; 14(5):987-92. DOI: 10.1093/carcin/14.5.987. View

14.

Santolini E, Pacini L, Fipaldini C, Migliaccio G, Monica N . The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol. 1995; 69(12):7461-71. PMC: 189684. DOI: 10.1128/JVI.69.12.7461-7471.1995. View

15.

Majumder M, Ghosh A, Steele R, Ray R, Ray R . Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol. 2001; 75(3):1401-7. PMC: 114046. DOI: 10.1128/JVI.75.3.1401-1407.2001. View

16.

Medema R, Macurek L . Checkpoint control and cancer. Oncogene. 2011; 31(21):2601-13. DOI: 10.1038/onc.2011.451. View

17.

McGivern D, Lemon S . Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene. 2011; 30(17):1969-83. PMC: 3642622. DOI: 10.1038/onc.2010.594. View

18.

Hwang H, Clurman B . Cyclin E in normal and neoplastic cell cycles. Oncogene. 2005; 24(17):2776-86. DOI: 10.1038/sj.onc.1208613. View

19.

Jones C, Murray C, Eastman D, Tassello J, Rice C . Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 2007; 81(16):8374-83. PMC: 1951341. DOI: 10.1128/JVI.00690-07. View

20.

Jin D . Molecular pathogenesis of hepatitis C virus-associated hepatocellular carcinoma. Front Biosci. 2006; 12:222-33. DOI: 10.2741/2060. View